QuantumScape earnings release, July 22, 2026

QuantumScape Corp (QS) · Form 8-K, Item 2.02 · Filed · SEC filing

Dear shareholders,

We’re pleased to provide you with an update on our activities over the past quarter.

Automotive Commercialization Update

We’re proud to report that we have taken a major step forward on automotive customer engagement: on June 18, we announced a partnership with Honda. This is a multi-year agreement aimed at advancing our solid-state lithium-metal battery technology for automotive and other applications in the Honda product portfolio.

Honda is a Top-10 global automaker renowned for its engineering excellence and product quality and has made significant investments in scaling up solid-state battery manufacturing capabilities. This partnership results from one of the most rigorous assessments of our technology to date. Our ceramic separator and anode-free lithium-metal architecture enables QS to provide solutions to unlock the full potential of solid-state batteries. With Honda’s diverse product portfolio, this collaboration also allows us an additional pathway to expand into new high-value markets.

QS CEO and President Dr. Siva Sivaram with Atsushi Ogawa, Chief Operating Officer, Research Center of Excellence, Honda R&D Co., Ltd. at the QS Solid-State Battery Symposium in Kyoto, Japan

Additionally, we recently updated our ongoing collaboration and licensing arrangement with Volkswagen PowerCo with an amended set of milestones and payments focused on automotive cell development, larger format cells and our future technology roadmap. We are also working with two other Top-10 automotive OEM customers under existing joint development agreements. We continue to strengthen our relationships with automakers in North America, Europe and Japan, and on this front, we have shipped cells to an additional automotive OEM customer.

New High-Value Markets

We see broad-based interest in our technology across a variety of applications beyond electric vehicles, including AI data centers and other advanced applications such as aerospace and defense. We believe that all these end markets can be served by our fundamental technology stack, but each customer can benefit from an individually tailored go-to-market approach.

In order to serve our diverse and growing customer base, we are establishing three business verticals: QSEV for electric vehicles, QSDC for AI data centers, and QSAS for advanced solutions in applications such as aerospace and defense.

Eagle Line Update

Work continues on one of the most important operational goals for 2026: demonstrating scalable production of QS technology using the Eagle Line, our highly automated pilot production line in San Jose. The Eagle Line serves several purposes: greater cell volumes allow us to meet customer demand for samples, higher throughput speeds up the process development cycle, and automated equipment serves as a proving ground for scaling up production.

Demonstrating scalable production of a unique technology on a first-of-a-kind automated line is a substantial challenge, and we have made significant operational progress with the Eagle Line. Core tools are showing uptime greater than 90%, key metrics of productivity are hitting our targets and we are currently ramping cell volumes and shipping samples to customers. As we continue to improve process stability and control, we aim to further double cell output in the second half of 2026 and anticipate customer sample shipments accelerating significantly across all three verticals.

We are orchestrating a network of partners within the QS technology ecosystem with the aim of scaling up cell production. As part of this effort, we are working closely with established battery equipment vendors to lay the groundwork for future factories. We also continue to collaborate with our ecosystem partners at Murata Manufacturing and Corning, working toward high-volume ceramic separator production using our Cobra process.

Technology Update

We have received consistent customer feedback that, in addition to the combination of energy density and power capability, the safety profile of our technology is highly valuable. Competing next-generation approaches, such as silicon or lithium-metal anodes with liquid electrolytes, can pose serious safety hazards. Compensating for those risks at the system level, as is the current standard, can negate most or all of the benefit of higher cell-level performance. In contrast, our proprietary ceramic separator is nonflammable and noncombustible, which enables an improved safety profile relative to lithium-ion cells.

QSE-5 Demonstrates Better Safety Than Competitor Cells

Thanks to the increased QSE-5 cell output from the Eagle Line, we are able to conduct larger-scale safety testing across a broad range of commercially relevant tests, including nail penetration, external short circuit, and thermal stability testing up to 300 °C. We are pleased to report that larger-scale testing is replicating our preliminary findings from previous generations of prototypes. We believe that our technology is a fundamentally safer design compared to both conventional and next-generation lithium-ion cells.

We have also seen customer interest for our technology in cell form factors that are larger than the QSE-5. One benefit of larger-format cells is improved packaging efficiency, which can result in higher cell-level energy density. In response to this customer interest, we have demonstrated that our Cobra process can produce larger-area separators for higher-capacity cell designs, which shows the flexibility and scalability of our ceramic separator technology to meet customer requirements.

Financial Outlook... (truncated). A table reconciling GAAP net loss and Adjusted EBITDA is available in the financial statement at the end of this shareholder letter.

Capital expenditures in the second quarter were $4.6M. Q2 capex was primarily composed of investment into our technology roadmap and associated facility spend. For full-year 2026, we lower our guidance for capex to between $27M and $37M, reflecting capital discipline and cost savings on specific capital projects.

Customer billings in Q2 were $10.8M. Customer billings as a metric represents the total value of all invoices issued by QS to our customers and partners in the period, regardless of accounting treatment. As a reminder, customer billings may vary from quarter to quarter due to fluctuations in activity as we progress through various phases of engagement. This operational metric is not a substitute for revenue under U.S. GAAP.

We ended Q2 with $859.0M in liquidity and will remain prudent with our strong balance sheet going forward. As always, we encourage investors to read more on our financial information, business outlook, and risk factors in our quarterly and annual SEC filings on our investor relations website.

Strategic Outlook

QS was founded with the mission to revolutionize energy storage. Today, it’s becoming clear just how consequential that mission is for the wider world. Transportation, computing, and defense are simultaneously undergoing fundamental transformations. Electric vehicles are reshaping the global automotive market, drones and unmanned systems are rewriting the rules of defense strategy, and AI is unlocking new capabilities for every business and person on the planet. These extraordinary developments all have one thing in common: they all need better batteries.

We are positioning our organization to take advantage of these technology transformations. QSDC is working to capitalize on exciting opportunities in the AI data center market, and QSAS is engaging customers in high-value aerospace and defense applications. With QSEV, we are advancing automotive commercialization with our four Top-10 OEM customers, including the newly announced Honda partnership. The Eagle Line is ramping up to enable increased customer shipments in the second half of the year, and we are investing in our future technology roadmap, with larger-format cells and more in the pipeline.

There is much work still to do, but our team has the talent and tenacity to overcome challenges as we industrialize our technology to make the most of these transformational opportunities. Thank you for your support, and we look forward to sharing more updates in the months ahead.

QuantumScape Corporation

Condensed Consolidated Balance Sheets (Unaudited)

(In Thousands)

QuantumScape Corporation

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(In Thousands, Except per Share Amounts)

QuantumScape Corporation

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In Thousands)

Net Loss to Adjusted EBITDA

Adjusted EBITDA is a non-GAAP supplemental measure of operating performance that does not represent and should not be considered an alternative to operating loss or cash flow from operations, as determined by GAAP. Adjusted EBITDA is defined as net income (loss) before interest expense, income tax expense, non-controlling interest, revaluations, impairments, stock-based compensation, depreciation and amortization expense, and other non-recurring charges. We use Adjusted EBITDA to measure the operating performance of our business, excluding specifically identified items that we do not believe directly reflect our core operations and may not be indicative of our recurring operations. Adjusted EBITDA may not be comparable to similarly titled measures provided by other companies due to potential differences in methods of calculations. A reconciliation of Adjusted EBITDA to net loss is as follows:

Financial statements

Income Statement

Three Months Ended June 30, — (In Thousands, Except per Share Amounts)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Operating expenses:Research and development82,533101,177167,103196,766
Operating expenses:General and administrative23,59422,40948,20350,395
Operating expenses:Total operating expenses106,127123,586215,306247,161
Operating expenses:Loss from operations-106,127-123,586-215,306-247,161
Other income (expense):Interest expense-466-516-944-1,044
Other income (expense):Interest income8,3558,94017,24518,709
Other income (expense):Other income (expense)191288166368
Other income (expense):Loss before income taxes-98,047-114,874-198,839-229,128
Other income (expense):Income tax (provision) benefit-193176-2007
Other income (expense):Net loss-98,240-114,698-199,039-229,121
Other comprehensive income (loss):Unrealized loss on marketable securities-610-213-1,638-541
Other comprehensive income (loss):Total comprehensive loss-98,850-114,911-200,677-229,662
Other comprehensive income (loss):Basic and Diluted net loss per share-0.16-0.2-0.32-0.41
Other comprehensive income (loss):Basic and Diluted weighted-average common shares outstanding617,077561,698614,062554,890

Income Statement

Three Months Ended June 30, (in thousands)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
GAAP net loss attributable to Common Stockholders-98,240-114,698-199,039-229,121
Interest expense (income), net-7,889-8,424-16,301-17,665
Other expense (income), net-191-288-166-368
Income tax provision (benefit)193-176200-7
Stock-based compensation27,32526,25557,83466,894
Non-GAAP operating loss-78,802-97,331-157,472-180,267
Depreciation and amortization expense(1)14,61334,31730,00552,693
Adjusted EBITDA-64,189-63,014-127,467-127,574

Balance Sheet

December 31, — (In Thousands) (in thousands)

June 30, – 2026December 31, – 2025
Current assetsCash and cash equivalents132,872230,524
Current assetsMarketable securities726,130740,283
Current assetsPrepaid expenses and other current assets10,08310,835
Current assetsTotal current assets869,085981,642
Current assetsProperty and equipment, net229,435251,449
Current assetsRight-of-use assets - operating lease32,09434,078
Current assetsRight-of-use assets - finance lease22,45119,394
Current assetsOther assets15,68021,593
Current assetsTotal assets1,168,7451,308,156
Current liabilitiesAccounts payable6,33611,819
Current liabilitiesAccrued liabilities14,96114,521
Current liabilitiesAccrued compensation and benefits17,15326,969
Current liabilitiesOperating lease liability, short-term4,9634,653
Current liabilitiesFinance lease liability, short-term3,7683,584
Current liabilitiesTotal current liabilities47,18161,546
Current liabilitiesOperating lease liability, long-term32,04334,481
Current liabilitiesFinance lease liability, long-term26,34428,282
Current liabilitiesOther liabilities15,20514,874
Current liabilitiesTotal liabilities120,773139,183
Current liabilitiesTotal stockholders’ equity1,047,9721,168,973
Current liabilitiesTotal liabilities and stockholders’ equity1,168,7451,308,156

Cash Flow

Three Months Ended June 30, — (In Thousands) (in thousands)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Operating activitiesNet loss-98,240-114,698-199,039-229,121
Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization13,38819,47028,14837,805
Adjustments to reconcile net loss to net cash used in operating activities:Amortization of right-of-use assets and non-cash lease expense2,5782,0685,1324,114
Adjustments to reconcile net loss to net cash used in operating activities:Accretion of discounts on marketable securities-3,756-4,065-8,254-9,113
Adjustments to reconcile net loss to net cash used in operating activities:Stock-based compensation expense27,32526,25557,83466,894
Adjustments to reconcile net loss to net cash used in operating activities:Write-off of property and equipment1,22514,8471,85714,888
Adjustments to reconcile net loss to net cash used in operating activities:Other-54-278-232-279
Changes in operating assets and liabilities:Prepaid expenses and other current assets and other assets1,2262,6368143,108
Changes in operating assets and liabilities:Accounts payable, accrued liabilities and accrued compensation and benefits769-5,328-111-6,860
Changes in operating assets and liabilities:Operating lease liability and other liabilities-1,209-2,747-2,408-4,025
Changes in operating assets and liabilities:Net cash used in operating activities-56,748-61,840-116,259-122,589
Investing activitiesPurchases of property and equipment-4,618-8,586-14,598-14,421
Investing activitiesProceeds from maturities of marketable securities282,290256,344514,243537,564
Investing activitiesPurchases of marketable securities-245,630-170,780-493,466-384,132
Investing activitiesOther46278220278
Investing activitiesNet cash provided by investing activities32,08877,2566,399139,289
Full release

(1) Depreciation and amortization expense includes accelerated depreciation and write-off of property and equipment no longer in use of approximately $1.2 million and $1.9 million, respectively, for the three and six months ended June 30, 2026, and approximately $14.8 million and $14.9 million, respectively, for the three and six months ended June 30, 2025.

Management’s Use of Non-GAAP Financial Measures

This letter includes certain non-GAAP financial measures as defined by SEC rules. These non-GAAP financial measures are in addition to, and not a substitute for or superior to, measures of financial performance prepared in accordance with U.S. GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their nearest GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. We urge you to review the reconciliations of our non-GAAP financial measures to the most directly comparable U.S. GAAP financial measures set forth in this letter, and not to rely on any single financial measure to evaluate our business.

Forward-Looking Statements... (truncated)ing commercialization strategies, expansion into new applications, including AI data centers, military, aerospace, and government applications, and the 2026 technology roadmap, among others, are forward-looking statements. Words like “may,” “will,” “can,” “estimate,” “permit,” “expect,” “plan,” “believe,” “designed to,” “seek,” “allow,” “focus,” “potential,” “target,” “forecast,” “should,” “would,” “could,” “continue,” “intend,” “anticipate,” “enable,” “work toward,” “prospective,” “future,” “up to,” “outlook,” “aim,” “position,” and the negative of such terms and other similar expressions identify forward-looking statements, though not all forward-looking statements include these words.

These forward-looking statements are not guarantees of future performance and are subject to a number of risks, uncertainties, and assumptions, including but not limited to, the following:

Technological development risks, including significant delays or technical challenges replicating and scaling performance from earlier low-volume sample cells, achieving the quality, consistency, reliability, safety, cost, and throughput required for commercial production, developing a cell architecture meeting all technical requirements and customer expectations, or achieving further advancements beyond the QSE-5 platform or meeting the requirements of our technology roadmap;

Production risks, including encountered or potential delays, unforeseen technical issues, and other obstacles in developing, acquiring, installing, and operating new equipment for automated or continuous flow processes like Cobra and the Eagle Line, including vendor delays, supply chain disruptions, and challenges in demonstrating scalable cell output on the Eagle Line or achieving the efficiencies necessary to support customer integration;

Personnel risks, including potential delays and cost overruns in hiring and retaining the talent needed to expand development and production, including under the amended Collaboration Agreement with PowerCo;

Infrastructure and supply chain risks, including challenges building out or scaling the Eagle Line and establishing supply relationships for required materials, components, or equipment, including in contract manufacturing relationships;

Commercialization risks, where delays in increasing sample production have previously slowed our development, and such delays could affect our sample delivery and delay or prevent successful demonstration, commercialization of our products, field testing, tailored product solutions for vehicle programs, entry into the IP License Agreement with PowerCo, or engagement with new partners across the battery value chain;

Risks related to our customer relationships, with Volkswagen and PowerCo, Honda, and our other automotive OEM partners, which could adversely affect our business and future prospects, including potential delays, difficulties, and technical challenges collaborating to industrialize our battery technology;

Milestone and licensing risks, including delays or difficulties meeting technical milestones, particularly those linked to program payments or required to trigger entry into the IP License Agreement and royalty prepayment, or difficulties in achieving the performance, quality, consistency, reliability, safety, cost and throughput required for commercial production and sale, scaling up the Eagle Line as a manufacturing blueprint to enable licensing partners to successfully bring our technology to gigawatt-hour scale in their own facilities, or readying our technology platform for transfer to prospective licensees, any of which could cause prospective customers and partners not to purchase cells or license our technology;

Operational and commercial restrictions, as certain agreements and relationships currently or may in the future restrict our operations, commercialization, and revenue;

Partnership and collaboration risks, as while our collaboration with Murata Manufacturing, Corning Incorporated, and other partners across the battery value chain could accelerate industrialization of our solid-state battery technology, there is no assurance these engagements, including investment in QS-proprietary hardware and systems, will progress beyond initial phases or achieve intended outcomes;

Cost control risks, including the inability to control costs tied to our operations and the components needed to build solid-state battery cells at competitive prices;

Financial risks, including exceeding current spend expectations, actual results differing materially from our financial guidance, including our full-year Adjusted EBITDA loss and capital expenditure guidance, requiring additional fundraising, including in public markets, which may dilute our investors’ ownership, or related to our customer billings, such as disputes or delays in payments and the consistency of billings;

Market and economic risks, including the inability to successfully adapt our technology for or penetrate new high-value markets beyond the automotive sector, including AI data centers, military, aerospace, and government applications, many of which remain at an early stage of customer engagement, with no assurance that customer interest will convert to development agreements, purchase commitments, or revenue, difficulties from changes in our economic and financial conditions, market conditions affecting demand for our technology, regulatory changes or changes to broader economic conditions, among other factors, potentially hindering success in the battery industry or undermining confidence in our long-term business among partners and customers;

Competition risks from major manufacturers, automotive OEMs, and new entrants, including conventional lithium-ion battery suppliers, in developing and commercializing solid-state battery technology; and

Intellectual property risks... (truncated)ive position.

The foregoing list of factors is not exhaustive. We caution readers not to place undue reliance on any forward-looking statements, which speak only as of their date. Except as required by law, we disclaim any duty to update forward-looking statements. If assumptions prove incorrect, actual results and projections could differ materially from those in forward looking statements. Additional information about these and other factors that could materially affect our actual results can be found in our SEC filings, available at www.sec.gov.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · QuantumScape earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.